Updates on three of six ongoing Phase III Ramucirumab trials to be presented
Eli Lilly and Company will present data from several molecules...
14 May 2012 | By Eli Lilly and Company
Eli Lilly and Company will present data from several molecules...
List view / Grid view
Eli Lilly and Company will present data from several molecules...
14 May 2012 | By Eli Lilly and Company
Eli Lilly and Company will present data from several molecules...
Studies provided basis for ongoing Phase I, II studies in…
2 April 2012 | By Eli Lilly and Company
Studies provided basis for ongoing Phase I, II studies in gastric, other cancers...
Data from an oncology pipeline molecule announced at the ASH…
12 December 2011 | By Eli Lilly and Company
Data from an oncology pipeline molecule announced at the ASH meeting...